Keyphrases
Hematological Malignancies
100%
Cell Therapy
100%
Natural Killer Cells
100%
Adaptive NK Cells
28%
Cancer Patients
14%
T Cells
14%
In Cancer
14%
Anti-leukemia
14%
Ex Vivo Expansion
14%
Cancer Cells
14%
Solid Cancer
14%
Expression Level
14%
Cell-mediated
14%
Leukemia Patients
14%
Strategies to Overcome
14%
CAR-NK Cells
14%
Adoptive Immunotherapy
14%
Low Expression
14%
Leukemic Cells
14%
Receptor Blockade
14%
Cell Recognition
14%
Checkpoint Molecules
14%
Malignant Disease
14%
HLA Class I Molecules
14%
T Cell Recognition
14%
Killing Activity
14%
Haploidentical Hematopoietic Stem Cell Transplantation
14%
Recent Approaches
14%
Memory-like
14%
Historical Role
14%
Medicine and Dentistry
Cell Therapy
100%
Hematologic Malignancy
100%
Natural Killer Cell
100%
T Cell
22%
Leukemia
22%
Malignant Neoplasm
11%
Ex Vivo
11%
Disease
11%
Cancer Cell
11%
Receptor Blocking
11%
Target Cell
11%
Adoptive Immunotherapy
11%
Chimeric Antigen Receptor Natural Killer Cell
11%
Haploidentical Hematopoietic Stem Cell Transplantation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Leukemia
66%
Malignant Neoplasm
66%
Receptor
33%
Disease
33%
Immunotherapy
33%
Immunology and Microbiology
Natural Killer Cell
100%
T Cell
22%
Adoptive Immunotherapy
11%
Cancer Cell
11%
Receptor Blocking
11%
Target Cell
11%
Chimeric Antigen Receptor Natural Killer Cell
11%
Haploidentical Hematopoietic Stem Cell Transplantation
11%
Biochemistry, Genetics and Molecular Biology
Natural Killer Cell
100%
T Cell
20%
Cancer Cell
10%
Receptor Blocking
10%
Haploidentical Hematopoietic Stem Cell Transplantation
10%
Target Cell
10%